Anticancer medicines (doxorubicin and methotrexate) conjugated with magnetic nanoparticles for targeting drug delivery through iron

Preparative Biochemistry and Biotechnology

Volumn 43, Issue 8, 2013, Pages 781-797

  Samra, Zahoor Qadir ^a   Ahmad, Snober ^a   Javeid, Mehwish ^a   Dar, Nadia ^b   Aslam, Muhammad Shahbaz ^a   Gull, Iram ^a   Ahmad, Mubashar Mustaneer ^c  

^a UNIVERSITY OF THE PUNJAB   (Pakistan)

^b Government Jinnah Degree for Women   (Pakistan)

^c SERVICES HOSPITAL   (Pakistan)

Author keywords

antibody; anticancer; drug delivery; FTIR; nanoparticles

Indexed keywords

ANTIBODY; ANTINEOPLASTIC AGENT; CROSS LINKING REAGENT; DOXORUBICIN; DRUG CARRIER; GLUTARALDEHYDE; IRON; MAGNETITE NANOPARTICLE; METHOTREXATE;

ANTIBODY SPECIFICITY; ARTICLE; B LYMPHOCYTE; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECT; HELA CELL; HUMAN; INFRARED SPECTROSCOPY; METABOLISM; PARTICLE SIZE; PH;

ANTIBODIES; ANTINEOPLASTIC AGENTS; B-LYMPHOCYTES; CELL SURVIVAL; CROSS-LINKING REAGENTS; DOXORUBICIN; DRUG CARRIERS; GLUTARAL; HELA CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; IRON; MAGNETITE NANOPARTICLES; METHOTREXATE; ORGAN SPECIFICITY; PARTICLE SIZE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84881338625     PISSN: 10826068     EISSN: 15322297     Source Type: Journal    
DOI: 10.1080/10826068.2013.782042     Document Type: Article

References (39)

1. Cai, S.;, Thati, S.;, Bagby, T.R.;, Diab, H.M.;, Davies, N.M.;, Cohen, M.S.;, Forrest, M.L. Localized Doxorubicin Chemotherapy With a Biopolymeric Nanocarrier Improves Survival and Reduces Toxicity in Xenografts of Human Breast Cancer. J. Cont. Rel. 2010, 146 (2), 212-218.
2. Sweatman, T.W.;, Israel, M. Anthracyclines in Cancer Therapeutics: Experimental and Clinical Agents. Teicher, B.A., Ed.; Humana Press, Totowa, NJ, 1996; pp. 113-136.
3. Wang, A.H.J.;, Gao, Y.G.;, Liaw, Y.C.;, Li, Y.K. 1991. Formaldehyde Cross-Links Doxorubicin and DNA Efficiently: HPLC and X-Ray Diffraction Studies. Biochemistry 1991, 30, 3812-3815.
4. Wang, X.;, Yang, L.;, Chen, Z.G.;, Shin, D.M. Application of Nanotechnology in Cancer Therapy and Imaging. CA Cancer J. Clin. 2008, 58 (2), 97-110. (Pubitemid 351521865)
5. Thrall, J.H. Nanotechnology and Medicine. Radiology 2004, 230, 315-318. (Pubitemid 38133784)
6. Akbarzadeh, A.;, Samiei, M.;, Davaran, S. Magnetic Nanoparticles: Preparation, Physical Properties, and Applications in Biomedicine. Nanosci. Res. Lett. 2012, 7 (1), 144.
7. Jendle, J.H.;, Karlberg, B.E. Intrapulmonary Administration of Insulin to Healthy Volunteers. J. Internal Med. 1996, 24092, 93-98. (Pubitemid 26298131)
8. Suh, W.H.;, Suslick, K.S.;, Stucky, G.D. Nanotechnology, Nanotoxicology, and Neuroscience. Prog. Neurobiol. 1990, 87 (3), 133-170.
9. O'Hagen, D.T.;, Illum, L. Absorption of Peptides and Proteins From the Respiratory Tract and Potential for Development of Locally Administered Vaccine. Crit. Rev. Ther. Drug. Carrier. Syst. 1990, 7 (1), 35-97. (Pubitemid 20355577)
10. Kreuter, J. Influence of the Surface Properties on Nanoparticle-Mediated Transport Drugs to the Brain. J. Nanosci. Nanotechnol. 2004, 4 (5), 484-488. (Pubitemid 39387399)
11. Sinha, R.;, Kim, G.J.;, Nie, S.;, Shin, D.M. Nanotechnology in Cancer Therapeutics: Bioconjugated Nanoparticles for Drug Delivery. Mol. Cancer. Ther. 2006, 5 (8), 1909-1917. (Pubitemid 44336561)
12. Niven, R.W. Delivery of Biotherapeutics by Inhalation Aerosol. Crit. Rev. Ther. Drug. Carrier. Syst. 1995, 12 (2-3), 151-231.
13. Tsapis, N.;, Bennett, D.;, Jackson, B.;, Weitz, D.A.;, Edwards, D.A. Trojan Particles: Large Porous Carriers of Nanoparticles for Drug Delivery. Proc. Natl. Acad. Sci. USA 2002, 99 (19), 12001-12005.
14. Senyei, A.;, Widder, K.;, Czerlinski, G. Magnetic Guidance of Drug-Carrying Microspheres. J. Appl. Phy. 1978, 49, 3578-3583.
15. Neuberger, T.;, Schopf, B.;, Hofmann, H.;, Hofmann, M.;, Rechenberg, B.V. Superparamagnetic Nanoparticles for Biomedical Applications: Possibilities and Limitations of a New Drug Delivery System. J. Mag. Magnet. Mater. 2005, 293 (1), 483-496. (Pubitemid 40608969)
16. Torchilin, V.P. Multifunctional Nanocarriers. Adv. Drug Deliv. Rev. 2006, 58 (14), 1532-1555. (Pubitemid 44822608)
17. Zhang, Y.;, Kohler, N.;, Zhang, M.Q. Surface Modification of Superparamagnetic Magnetite Nanoparticles and Their Intracellular Uptake. Biomat. 2002, 23 (7), 1553-1561. (Pubitemid 34158578)
18. Lubbe, A.S.;, Bergemann, C.;, Riess, H.;, Schriever, F.;, Reichardt, P.;, Possinger, M.;, Matthias, B.;, Dorken, F.;, Herrmann, R.;, Gurtler, P.;, Hohenberger, H.;, Haas, R.;, Sohr, B.;, Sander, A.J.;, Lemke, D.;, Ohlendorf, W.;, Huhnt, D. Clinical Experiences With Magnetic Drug Targeting: A Phase I Study With 4′-Epidoxorubicin in 14 Patients With Advanced Solid Tumors. Cancer Res. 1996, 56 (20), 4686-4693. (Pubitemid 26338071)
19. Lubbe, A.S.;, Alexiou, C.;, Bergemann, C. Clinical Applications of Magnetic Drug Targeting. J. Surg. Res. 2001, 95 (2), 200-206. (Pubitemid 34953556)
20. Johnston, A.;, Gudjonsson, J.E.;, Sigmundsdottir, H.;, Ludviksson, B.R.; and, Valdimarsson, H. The Anti-Inflammatory Action of Methotrexate Is Not Mediated by Lymphocyte Apoptosis but by the Suppression of Activation and Adhesion Molecules. Clin. Immunol. 2005, 11492, 154-163. (Pubitemid 40082381)
21. O'Brien, M.;, Wigler, N.M.;, Inbar, R.;, Rosso, E.;, Grischke, A.;, Santoro, R.;, Catane, D.G.;, Kieback, P.;, Tomczak, S.P.;, Ackland, F.;, Orlandi, L.;, Mellars, L.A.;, Tendler, C. Reduced Cardiotoxicity and Comparable Efficacy in a Phase III Trial of Pegylated Liposomal-Cl (CAELYX™/Doxil) Versus Conventional Doxorubicin for First-Line Treatment of Metastatic Breast Cancer. Ann. Oncol. 2004, 15 (3), 440-449. (Pubitemid 38444547)
22. Olga, M.;, Nataliya, D.;, Alexandre, D. Doxorubicin Magnetic Conjugate Targeting Upon Intravenous Injection Into Mice: High Gradient Magnetic Field Inhibits the Clearance of Nanoparticles From the Blood. J. Mag. Magnet. Mater. 2005, 293 (1), 473-482.
23. Rose, P.G. Pegylated Liposomal Doxorubicin: Optimizing the Dosing Schedule in Ovarian Cancer. Oncol. 2005, 10 (3), 205-214. (Pubitemid 40463158)
24. Osama, A.H.;, Zinadha, A.;, ElHamidy, S.M.;, Reffat, N.A.A. Mesoscopic Studies on Toxic Effect of Doxorubicin on Rat Cardiac Muscles. Int. J. Nano. Biomat. 2009, 2, 386-395.
25. Kosasih, A.;, Bowman, B.;, Wigent, R.J.;, Ofner, C.M. Characterization and In Vitro Release of Methotrexate From Gelatin/Methotrexate Conjugates Formed Using Different Preparation Variables. Int. J. Pharm. 2000, 204 (1-2), 8-19.
26. Nesbit, M.;, Krivit, W.;, Heyn, R.;, Sharp, H. Acute and Chronic Effects of Methotrexate on Hepatic, Pulmonary and Skeletal Systems. Cancer 1976, 37 (2), 1048-1057.
27. Samra, Z.Q.;, Dar, N.;, Athar, M.A. Biocatalytic Activity of Recombinant Human β-Mannosidase Immobilized Onto Magnetic Nanoparticles for Bioprocess. Prep. Biochem. Biotechnol. 2012, 42 (1), 97-112.
28. Liao, M.H.;, Chen, D.H. Preparation and Characterization of a Novel Magnetic Nanoadsorbant. J. Mater. Chem. 2002, 12, 3654-3659.
29. Svehla, G. Vogel's Qualitative Inorganic Analysis., 7th ed.; Pearson Education, Delhi, India, 2011.
30. Harlow, E.D.;, Lane, D. Antibodies, A Laboratory Manual. Cold Spring Harbour Labs., Cold Spring Harbor, NY, 1988.
31. Xiong, X.B.;, Ma, Z.;, Lai, R.;, Lavasanifar, A. The Therapeutic Response to Multifunctional Polymeric Nano-Conjugates in the Targeted Cellular and Subcellular Delivery of Doxorubicin. Biomaterials 2010, 31, 757-768.
32. Dsouza, A.J.M.;, Topp, E.M. Release From Polymeric Prodrugs: Linkages and Their Degradation. J. Pharm. SCI-US 2004, 93 (8), 1962-1979. (Pubitemid 39045479)
33. Chun, C.J.;, Lee, S.M.;, Kim, C.W.;, Hong, K.Y.;, Kim, S.Y.;, Yang, H.K.;, Song, S.C. Doxorubicin-Polyphosphazene Conjugate Hydrogels for Locally Controlled Delivery of Cancer Therapeutics. Biomaterials 2009, 30, 4752-4762.
34. Daigeler, A.;, Klein-Hitpass, L.;, Chromik, A.M.;, Müller, O.;, Hauser, J.;, Homann, H.H.;, Steinau, H.U.;, Ehnhardt, M. 2008. Heterogeneous in vitro effects of doxorubicin on gene expression in primary human liposarcoma cultures. BMC Cancer 2008, 8, 313.
35. Kohler, N.;, Sun, C.;, Fichtenholtz, A.;, Gunn, J.;, Fang, C.;, Zhang, M. Methotrexate-Immobilized Poly(Ethylene Glycol) Magnetic Nanoparticles for MR Imaging and Drug Delivery. Small 2006, 2 (6), 785-792. (Pubitemid 43745151)
36. Moghimi, S.M.;, Hunte, A.C.;, Murray, J.C. Long Circulating and Target Specific Nanoparticles: Theory to Practice. Pharmacol, Rev. 2001, 53 (2), 283-318.
37. Bertorelle, F.;, Wilhelm, C.;, Roger, J.;, Gazeau, F.;, Menager, C.;, Cabuil, V. Fluorescence Modified Super Paramagnetic Nanoparticles: Intracellular Uptake and Use in Cellular Imaging. Langmuir 2006, 22 (12), 5385-5391. (Pubitemid 43954516)
38. Zhang, S.;, Li, J.;, George, L.F.;, Bao, G.;, Suresh, S. Size-Dependent Endocytosis of Nanoparticles. Adv. Mater. 2009, 21 (4), 419-424.
39. Pantic, I. Magnetic Nanoparticles in Cancer Diagnosis and Treatment: Novel Approaches. Rev. Adv. Mater. Sci. 2010, 26, 67-73.